Abstract
Tinea corporis is an infective skin disease resulting from invasion and proliferation by the causal fungi in the stratum corneum. The fungi most commonly involved are Microsporumcanis, Trichophyton rubrum, and Trichophyton mentagrophytes. It most commonly involves exposed parts of the body, but can affect any site. Typical lesions are annular in shape, with a raised scaling erythematous edge. The presence of perifollicular granulomatous papules (Majocchi’s granuloma) is a definite indication for systemic treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- DLSO:
-
Distal and lateral subungual onychomycosis
- FDA:
-
Food and Drug Administration
- M.:
-
Microsporum
- OSI:
-
Onychomycosis severity index
- PDT:
-
Photodynamic therapy
- PSO:
-
Proximal subungual onychomycosis
- RCT:
-
Randomized controlled trial
- SO:
-
Superficial onychomycosis
- T. :
-
Trichophyton
- TDO:
-
Totally dystrophic onychomycosis
References
Amichai B, et al. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study. Br J Dermatol. 2010;162(1):46–50.
Baran R, et al. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol. 2009;23(7):773–81.
Beutner K, et al. Interim results of a multi-center study to evaluate the safety and efficacy of topically applied AN2690 5.0% and 7.5% solutions for the treatment of onychomycosis of the great toenail. J Am Acad Dermatol. 2009; 60(3 Suppl).
Carney C, et al. A new classification system for grading the severity of onychomycosis: onychomycosis severity index. Arch Dermatol. 2011;147(11):1277.
Chauvin D, et al. Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial. Mycoses. 2008;51(1):1–6.
Dominicus R, et al. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis. Br J Dermatol. 2012;166(6):1360–2.
Elewski B, et al. A randomized, placebo-and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis. Br J Dermatol. 2012;166(2):389–98.
Elewski BE, et al. Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013;68(4):600–8.
Emtestam L, Kaaman T, Rensfeldt K. Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: results of a 24-week, double-blind, placebo-controlled study. Mycoses. 2012;55(6):532–40.
Hafeez F, et al. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers. Drug Dev Ind Pharm. 2014;40:838–44.
Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol. 2011;65(6):1219–27.
Ikeda S, Kanoya Y, Nagata S. Effects of a foot bath containing green tea polyphenols on interdigital tinea pedis. Foot (Edinb). 2013;23:58–62.
Jarratt M, et al. Luliconazole for the treatment of interdigital tinea pedis: a double-blind, vehicle-controlled study. Cutis. 2013;91(4):203–10.
Jones T, Tavakkol A. Safety and tolerability of luliconazole solution 10-percent in patients with moderate to severe distal subungual onychomycosis. Antimicrob Agents Chemother. 2013;57(6):2684–9.
Landsman AS, Robbins AH. Treatment of mild, moderate, and severe onychomycosis using 870-and 930-nm light exposure some follow-up observations at 270 days. J Am Podiatr Med Assoc. 2012;102(2):169–71.
Satchell AC, et al. Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Aust J Dermatol. 2002;43(3):175–8.
Tietz HJ, et al. Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study. Mycoses. 2013;56:414–21.
Zhang R, et al. Long-pulse Nd: YAG 1064-nm laser treatment for onychomycosis. Chin Med J (Engl). 2012;125(18):3288–91.
Further Reading
Banerjee M, et al. Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis. Indian J Dermatol. 2011;56(6):657.
Baran R, Tosti A. Chemical avulsion with urea nail lacquer. J Dermatol Treat. 2002;13(4):161–4.
Baran R, et al. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement. Br J Dermatol. 2007;157(1):149–57.
Bell-Syer S, Khan S, Torgerson D. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev. 2012;10:CD003584.
Chang C-H, et al. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Am J Med. 2007;120(9):791–8.e3.
Chen C, et al. A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children. Pediatr Dermatol. 2010;27(5):459–62.
Faergemann J, et al. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. Br J Dermatol. 1997;136(4):575–7.
Figueiredo Souza L, Souza S, Botelho A. Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis. Dermatol Ther. 2014;27(1):43–7.
Ginter-Hanselmayer G, et al. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007;50(s2):6–13.
González U, et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2007;(4):CD004685.
Grover C, et al. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. Br J Dermatol. 2007;157(2):364–8.
Gupta AK, Drummond-Main C. Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis. Pediatr Dermatol. 2013;30(1):1–6.
Gupta A, et al. Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol. 2013a;27(3):267–72.
Gupta AK, Drummond-Main C, Paquet M. Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment. J Dermatol Treat. 2013b;24:75–80.
Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd: YAG 1064-nm laser. J Cosmet Laser Ther. 2011;13(1):2–5.
Hughes R, et al. Corkscrew hair: a new dermoscopic sign for diagnosis of tinea capitis in black children. Arch Dermatol. 2011;147(3):355.
Jerajani H, et al. Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: a pilot study. Indian J Dermatol. 2013;58(1):34.
Lecha M, et al. Treatment options–development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005;19(s1):25–33.
Miteva M, Tosti A. Hair and scalp dermatoscopy. J Am Acad Dermatol. 2012;67(5):1040–8.
Ngatu NR, et al. Brazilian green propolis extracts improve tinea pedis interdigitalis and tinea corporis. J Altern Complement Med. 2012;18(1):8–9.
Nozickova M, et al. A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis. Int J Dermatol. 1998;37(9):703–5.
Pereda J, et al. Efficacy of flutrimazole 1% powder in the treatment of tinea pedis. Mycoses. 2003;46(3–4):126–31.
Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol. 2010;62(3):411–4.
Romero-Cerecero O, et al. Therapeutic effectiveness of ageratina pichinchensis on the treatment of chronic interdigital tinea pedis: a randomized, double-blind clinical trial. J Altern Complement Med. 2012;18(6):607–11.
Rotta I, et al. Efficacy of topical antifungals in the treatment of dermatophytosis a mixed-treatment comparison meta-analysis involving 14 treatments topical antifungals for dermatophytosis. JAMA Dermatol. 2013;149(3):341–9.
Rudnicka L, et al. Tinea capitis. In Atlas of trichoscopy. Springer, London; 2012. p. 361–69.
Sharma A, et al. Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. Mycoses. 2011;54(3):217–22.
Shemer A, et al. Treatment of tinea capitis – griseofulvin versus fluconazole – a comparative study. J Dtsch Dermatol Ges. 2013;11:737–42.
Sigurgeirsson B, et al. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years. J Eur Acad Dermatol Venereol. 2010;24(8):910–5.
Sigurgeirsson B, et al. A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis. J Am Acad Dermatol. 2013;69:416.
Singal A, et al. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial. J Dermatol Treat. 2005;16(5–6):331–5.
Tey HL, Tan ASL, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 2011;64(4):663–70.
Tosti A. Practice gaps–trichoscopy in clinical care: comment on“ Corkscrew hair”. Arch Dermatol. 2011;147(3):356.
Trivedi N, Shah P. A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosis. Indian J Dermatol. 2010;55(2):198.
Weinberg J, Koestenblatt E. Treatment of interdigital tinea pedis: once-daily therapy with sertaconazole nitrate. J Drugs Dermatol. 2011;10(10):1135.
Yin Z, Xu J, Luo D. A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole. J Dermatol Treat. 2012;23(6):449–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tosti, A., Shaurya, K., Piraccini, B.M. (2015). Dermatophyte Infections. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_21
Download citation
DOI: https://doi.org/10.1007/978-3-662-45139-7_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45138-0
Online ISBN: 978-3-662-45139-7
eBook Packages: MedicineMedicine (R0)